Allergan, Inc. Receives FDA Approval For COMBIGAN? (Brimonidine Tartrate/timolol Maleate Ophthalmic Solution) 0.2%/0.5%

Allergan, Inc. (NYSE:AGN) announced that the U.S. Food and Drug Administration has approved COMBIGAN? (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, an alpha adrenergic receptor agonist with a beta adrenergic receptor inhibitor, for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. [click link for full article]

More: continued here

Filed under: Eye Health on November 7th, 2007